Investors looking for a straightforward way to build a globally diversified portfolio often consider asset-allocation ETFs that combine equities and fixed income in one holding. AOR and AVMA both target the moderate allocation space, aiming for a balanced risk level between conservative and aggressive approaches. Because they serve similar investor needs, it is worth examining the structural differences in cost, liquidity, methodology, and factor exposure that can add up over time. In this post I review how each fund is constructed, where their exposures diverge, and what current AI-driven signals suggest.
Launched in November 2008 and managed by BlackRock's iShares, AOR follows a passive fund-of-funds approach tied to the S&P Target Risk Growth Index. It typically holds around eight underlying iShares ETFs, with equity exposure near 60% and fixed income near 40%. Key positions include IVV (roughly 34%), IUSB (roughly 33%), IDEV (about 17%), IEMG (about 6%), and IAGG (about 6%).
The net expense ratio stands at 0.15%, which is competitive in the category. The fund uses a rules-based, market-cap-weighted method with periodic rebalancing and delivers broad coverage across U.S. large-, mid-, and small-cap equities plus international developed and emerging markets and diversified bonds. Its large asset base and solid trading volume support narrow bid-ask spreads.
AVMA, launched in June 2023 by Avantis Investors, is an actively managed fund of funds that invests in roughly 17 to 18 underlying Avantis ETFs. Its target allocation is approximately 47% U.S. equity, 12% non-U.S. developed equity, 6% emerging-markets equity, 2% sector equity, and 33% fixed income. This equity-to-fixed-income split is similar to AOR, yet the fund applies active tilts.
Top holdings include AVUS (about 29%), AVIG (roughly 18–20%), AVLV (about 10%), AVGB (about 8%), AVSF (about 8%), and AVDE (about 7%). The strategy overweight securities with higher expected returns, emphasizing value, profitability, and smaller-capitalization names rather than market-cap weights. Its net expense ratio is 0.21% (0.23% gross with a 0.02% fee waiver), and assets remain under $100 million with lower trading volume.
Both funds sit in the multi-asset, target-risk category where results depend on equity trends and fixed-income yields. The present setting features resilient yet concentrated equity markets driven by a narrow group of large-cap technology names, alongside a bond market that now offers meaningful yields after years near zero. This creates a mixed picture for moderate-allocation ETFs: the bond portion can provide income and some downside cushion, while the equity sleeve carries concentration risk.
For a factor-tilted approach like AVMA, the environment plays out differently. Value and smaller-cap biases tend to perform when market breadth improves and leadership shifts away from mega-cap growth stocks, but they can lag in momentum-driven periods. Ongoing policy and geopolitical factors continue to shape both equity and bond components.
Recent cycles have shown the expected divergence based on each fund's style. AVMA's factor tilts have at times supported competitive results, especially when value and small-cap areas advanced, though its shorter history and smaller scale bring additional considerations beyond returns alone. AOR has delivered steady, index-like exposure with a track record back to 2008 that spans multiple market environments.
On risk measures, AOR's market-cap-weighted design produces a beta below the broad equity market thanks to its bond allocation. AVMA maintains a comparable moderate profile but adds style risk from its value and size tilts. Liquidity stands out as a key distinction: AOR typically trades with very tight spreads, while AVMA's thinner volume can lead to wider costs on larger trades. For long-term, cost-conscious investors these differences in expenses and trading friction matter to overall results. I also checked this using Tickeron’s AI Screener to see how the two compare on liquidity and cost metrics.
In my own workflow I occasionally rely on Tickeron's AI Screener when comparing ETFs. It allows quick filtering by cost, liquidity, factor exposure, and performance history, which helps surface structural differences efficiently without manual data pulls. This approach has been useful for evaluating holdings like AOR and AVMA side by side.
Based on the structural details, Tickeron's AI currently points toward AOR over AVMA. The case rests on AOR's lower 0.15% expense ratio versus 0.21%, its stronger liquidity and tighter spreads, nearly two decades of history, and broad market-cap diversification. While AVMA's active value and profitability biases could deliver outperformance in favorable conditions, its smaller asset base, shorter record, and higher costs add structural considerations. On balance of cost efficiency, diversification, consistency, and risk profile, AOR appears the more solid core option for many investors.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
AOR moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend. In 22 of 32 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 69%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AOR as a result. In 54 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
The Moving Average Convergence Divergence Histogram (MACD) for AOR turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 35 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AOR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
The Aroon Indicator for AOR entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where AOR advanced for three days, in 230 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
AOR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.